In both TSC and sporadic (non-inherited) LAM patients, mutations in TSC2 have been related to increased active β-catenin in kidney angiomyolipomas and pulmonary LAM cells [40,41]. Here, TSC2 is linked to lymphangioleiomyomatosis.